Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: A conceptual model starting with the patient perspective

Health and Quality of Life Outcomes

Volumn 6, Issue , 2008, Pages

  Mathias, Susan D ^a   Gao, Sue K ^b   Miller, Kimberly L ^c   Cella, David ^d   Snyder, Claire ^e   Turner, Ralph ^f   Wu, Albert ^e   Bussel, James B ^g   George, James N ^h   McMillan, Robert ⁱ   Wysocki, Diane Kholos ^j   Nichol, Janet L ^b  

^a Health Outcomes Solutions   (United States)

^b AMGEN INC   (United States)

^c ICON CLINICAL RESEARCH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f Phase V Technologies Inc   (United States)

^g WEILL CORNELL MEDICAL CENTER   (United States)

^h UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

ⁱ SCRIPPS RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF NEBRASKA AT KEARNEY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETANERCEPT; IMMUNOGLOBULIN; RHESUS D ANTIBODY; RITUXIMAB;

ANGER; ANXIETY; ARTICLE; CHRONIC DISEASE; COMBINATION CHEMOTHERAPY; CONCEPTUAL FRAMEWORK; DEPRESSION; EMOTIONAL STABILITY; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFORMATION PROCESSING; INFORMATION RETRIEVAL; INSOMNIA; LAPAROSCOPIC SURGERY; LEISURE; MOOD DISORDER; MOON FACE; OUTCOMES RESEARCH; PREGNANCY OUTCOME; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCTIVE HEALTH; RESTLESSNESS; SELF CONCEPT; SIDE EFFECT; SOCIAL BEHAVIOR; SPLENECTOMY; SYMPTOMATOLOGY; THROMBOCYTE COUNT; TREATMENT RESPONSE; WEIGHT GAIN; WORK; ADOLESCENT; ADULT; FEMALE; HEALTH STATUS; IMMUNOPATHOLOGY; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REPRODUCIBILITY; TEACHING HOSPITAL; THEORETICAL MODEL; THROMBOCYTOPENIC PURPURA; UNITED STATES;

ADOLESCENT; ADULT; CALIFORNIA; CHRONIC DISEASE; FEMALE; FOCUS GROUPS; HEALTH STATUS; HOSPITALS, TEACHING; HUMANS; IMMUNE SYSTEM DISEASES; MALE; MODELS, THEORETICAL; NEW YORK CITY; OKLAHOMA; PSYCHOMETRICS; PURPURA, THROMBOCYTOPENIC; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIAL BEHAVIOR;

EID: 41549141794     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-6-13     Document Type: Article

References (60)

1. Cines DB Blanchette VS Immune thrombocytopenic purpura The New England journal of medicine 2002, 346(13):995-1008. 10.1056/NEJMra010501 11919310
2. George JN Management of patients with refractory immune thrombocytopenic purpura J Thromb Haemost 2006, 4(8):1664-1672. 10.1111/ j.1538-7836.2006.02013.x 16879206
3. Harrington WJ Minnich V Hollingsworth JW Moore CV Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura J Lab Clin Med 1951, 38(1):1-10. 14850832
4. George JN Diagnosis, clinical course, and management of idiopathic thrombocytopenic purpura Curr Opin Hematol 1996, 3(5):335-340. 9372098
5. Kaye JA Schoonen M Fryzek J ITP incidence and mortality in UK General Practice Research Database (GPRD): Vienna, Austria. 2007
6. Burden of illness of idiopathic thrombocytopenic purpura (ITP) - an overview Cerner Health Insights, Editor 2004 1-71
7. Cohen YC Djulbegovic B Shamai-Lubovitz O Mozes B The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts Arch Intern Med 2000, 160(11):1630-1638. 10.1001/archinte.160.11.1630 10847256
8. McMillan R Therapy for adults with refractory chronic immune thrombocytopenic purpura Ann Intern Med 1997, 126(4):307-314. 9036803
9. Wong GC Lee LH A study of idiopathic thrombocytopenic purpura (ITP) patients over a ten-year period Ann Acad Med Singapore 1998, 27(6):789-793. 10101551
10. George JN Treatment options for chronic idiopathic (immune) thrombocytopenic purpura Seminars in hematology 2000, 37(1 Suppl 1):31-34. 10.1016/S0037-1963(00)90116-1 10676922
11. George JN el-Harake MA Raskob GE Chronic idiopathic thrombocytopenic purpura The New England journal of medicine 1994, 331(18):1207-1211. 10.1056/NEJM199411033311807 7935660
12. Aledort LM Lyons RM Okano G Levenque J Restrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use: Orlando, Florida. 2006
13. Kojouri K Vesely SK Terrell DR George JN Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications Blood 2004, 104(9):2623-2634. 10.1182/blood-2004-03-1168 15217831
14. Braendstrup P Bjerrum OW Nielsen OJ Jensen BA Clausen NT Hansen PB Andersen I Schmidt K Andersen TM Peterslund NA Birgens HS Plesner T Pedersen BB Hasselbalch HC Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura American Journal of Hematology 2005, 78(4):275-280. 10.1002/ ajh.20276 15795920
15. U.S. Food and Drug Administration Draft - Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims Rockville, MD, U.S. Department of Health and Human Services 2006.
16. Committee for Medicinal Products for Human Use Reflection Paper on the Regulatotory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products London, European Medicines Agency 2005
17. Mathias SD Bussel JB George JN McMillan R Okano GJ Nichol JL A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation Health and quality of life outcomes 2007, 5:11. 10.1186/ 1477-7525-5-11 17316442 1808052
18. Mathias SD Bussel JB George JN McMillan R Okano GJ Nichol JL A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: Psychometric testing in an open-label clinical trial Clinical therapeutics 2007, 29(5):950-962. 10.1016/j.clinthera.2007.05.005 17697914
19. Wilson IB Cleary PD Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes JAMA 1995, 273(1):59-65. 10.1001/jama.273.1.59 7996652
20. Finfgeld-Connett D Qualitative concept development: Implications for nursing research and knowledge Nursing forum 2006, 41(3):103-112. 10.1111/j.1744-6198.2006.00045.x 16879145
21. Andres E Zimmer J Noel E Kaltenbach G Koumarianou A Maloisel F Idiopathic thrombocytopenic purpura: A retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol Drugs Aging 2003, 20(11):841-846. 10.2165/ 00002512-200320110-00005 12964890
22. Sandler SG Novak SC Roland B The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin American Journal of Hematology 2000, 63(3):156-158. 10.1002/ (SICI)1096-8652(200003)63:3<156::AID-AJH9>3.0.CO;2-4 10679807
23. McMillan R Durette C Long-term outcomes in adults with chronic ITP after splenectomy failure Blood 2004, 104(4):956-960. 10.1182/ blood-2003-11-3908 15100149
24. Cordera F Long KH Nagorney DM McMurtry EK Schleck C Ilstrup D Donohue JH Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura: Clinical and economic analysis Surgery 2003, 134(1):45-52. 10.1067/msy.2003.204 12874582
25. Lozano-Salazar RR Herrera MF Vargas-Vorackova F Lopez-Karpovitch X Laparoscopic versus open splenectomy for immune thrombocytopenic purpura Am J Surg 1998, 176(4):366-369. 10.1016/S0002-9610(98)00209-8 9817257
26. Tsereteli Z Smith CD Branum GD Galloway JR Amerson RJ Chakaraborty H Hunter JG Are the favorable outcomes of splenectomy predictable inpatients with idiopathic thrombocytopenic purpura (ITP)? Surg Endosc 2001, 15(12):1386-1389. 11965451
27. Delaitre B Blezel E Samama G Barrat C Gossot D Bresler L Meyer C Heyd B Collet D Champault G Laparoscopic splenectomy for idiopathic thrombocytopenic purpura Surg Laparosc Endosc Percutan Tech 2002, 12(6):412-419. 10.1097/00129689-200212000-00005 12496547
28. Ojima H Kato T Araki K Okamura K Manda R Hirayama I Hosouchi Y Nishida Y Kuwano H Factors predicting long-term responses to splenectomy in patients with idiopathic thrombocytopenic purpura World J Surg 2006, 30(4):553-559. 10.1007/s00268-005-7964-0 16568220
29. Watson DI Coventry BJ Chin T Gill PG Malycha P Laparoscopic versus open splenectomy for immune thrombocytopenic purpura Surgery 1997, 121(1):18-22. 10.1016/S0039-6060(97)90177-X 9001546
30. Kang CM Lee JG Kim KS Choi JS Lee WJ Kim BR What we learned from the experience of laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura (ITP) - single surgeon experiences Surg Laparosc Endosc Percutan Tech 2006, 16(3):151-155. 10.1097/ 00129689-200606000-00006 16804457
31. Khan LR Nixon SJ Laparoscopic splenectomy is a better treatment for adult ITP than steroids - it should be used earlier in patient management. Conclusions of a ten-year follow-up study Surgeon 2007, 5(1):3-4, 6-8. 17313122
32. Cooper N Woloski BM Fodero EM Novoa M Leber M Beer JH Bussel JB Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood 2002, 99(6):1922-1927. 10.1182/ blood.V99.6.1922 11877261
33. Bennett CL Weinberg PD Golub RM Bussel JB The potential for treatment of idiopathic thrombocytopenic purpura with anti-D to prevent splenectomy: a predictive cost analysis Seminars in hematology 2000, 37(1 Suppl 1):26-30. 10.1016/S0037-1963(00)90115-X 10676921
34. Bussel JB Eldor A Kelton JG Varon D Brenner B Gillis S Angiolillo A Kulkarni R Abshire TC Kelleher J IGIV-C, a novel intravenous immunoglobulin: Evaluation of safety, efficacy, mechanisms of action, and impact on quality of life Thromb Haemost 2004, 91(4):771-778. 15045139
35. McMinn JR Jr. Cohen S Moore J Lilly S Parkhurst J Tarantino MD Terrell DR George JN Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept American Journal of Hematology 2003, 73(2):135-140. 10.1002/ajh.10331 12749017
36. McMillan R Long-term outcomes after treatment for refractory immune thrombocytopenic purpura The New England journal of medicine 2001, 344(18):1402-1403. 10.1056/NEJM200105033441815 11336065
37. Bussel JB Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura Seminars in hematology 2000, 37(1 Suppl 1):1-4. 10.1016/ S0037-1963(00)90110-0 10676916
38. Kahn MJ McCrae KR Splenectomy in immune thrombocytopenic purpura: Recent controversies and long-term outcomes Curr Hematol Rep 2004, 3(5):317-323. 15341697
39. Sandler SG The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura Seminars in hematology 2000, 37(1 Suppl 1):10-12. 10.1016/S0037-1963(00)90112-4 10676918
40. Sandler SG Tutuncuoglu SO Immune thrombocytopenic purpura - current management practices Expert Opin Pharmacother 2004, 5(12):2515-2527. 10.1517/14656566.5.12.2515 15571469
41. Suri V Aggarwal N Saxena S Malhotra P Varma S Maternal and perinatal outcome in idiopathic thrombocytopenic purpura (ITP) with pregnancy Acta Obstet Gynecol Scand 2006, 85(12):1430-1435. 17260217
42. Borna S Borna H Khazardoost S Maternal and neonatal outcomes in pregnant women with immune thrombocytopenic purpura Arch Iran Med 2006, 9(2):115-118. 16649352
43. Webert KE Mittal R Sigouin C Heddle NM Kelton JG A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura Blood 2003, 102(13):4306-4311. 10.1182/blood-2002-10-3317 12947011
44. Devendra K Koh LP Pregnancy in women with idiopathic thrombocytopaenic purpura Ann Acad Med Singapore 2002, 31(3):276-280. 12061285
45. Ali R Ozkalemkas F Ozcelik T Ozkocaman V Ozan U Kimya Y Koksal N Bulbul-Baskan E Develioglu O Tufekci M Tunali A Idiopathic thrombocytopenic purpura in pregnancy: A single institutional experience with maternal and neonatal outcomes Ann Hematol 2003, 82(6):348-352. 10.1007/s00277-003-0665-6 12734677
46. Iyori H Fujisawa K Akatsuka J Thrombocytopenia in neonates born to women with autoimmune thrombocytopenic purpura Pediatr Hematol Oncol 1997, 14(4):367-373. 9211541
47. Parnas M Sheiner E Shoham-Vardi I Burstein E Yermiahu T Levi I Holcberg G Yerushalmi R Moderate to severe thrombocytopenia during pregnancy Eur J Obstet Gynecol Reprod Biol 2006, 128(1-2):163-168. 10.1016/ j.ejogrb.2005.12.031 16533554
48. Salawu L Durosinmi MA Immune thrombocytopaenic purpura: 11-year experience in Ile-Ife, Nigeria Afr J Med Med Sci 2001, 30(1-2):99-103. 14510161
49. Portielje JE Westendorp RG Kluin-Nelemans HC Brand A Morbidity and mortality in adults with idiopathic thrombocytopenic purpura Blood 2001, 97(9):2549-2554. 10.1182/blood.V97.9.2549 11313240
50. Frederiksen H Schmidt K The incidence of idiopathic thrombocytopenic purpura in adults increases with age Blood 1999, 94(3):909-913. 10419881
51. Simpson KN Coughlin CM Eron J Bussel JB Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy Seminars in hematology 1998, 35(1 Suppl 1):58-64. 9523750
52. Cooper N Bussel J The pathogenesis of immune thrombocytopaenic purpura Br J Haematol 2006, 133(4):364-374. 10.1111/j.1365-2141.2006.06024.x 16643442
53. Vesely SK Perdue JJ Rizvi MA Terrell DR George JN Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: A systematic review Ann Intern Med 2004, 140(2):112-120. 14734334
54. Ruggeri M Fortuna S Rodeghiero F Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: A critical appraisal from literature analysis Pediatr Blood Cancer 2006, 47(5 Suppl):653-656. 10.1002/pbc.20983 16933241
55. Matzdorff A Arnold G Treatment of chronic immune thrombocytopenic purpura: The patients' perspective Eur J Haematol 2007, 78(5):381-388. 10.1111/j.1600-0609.2007.00829.x 17331128
56. Zhou Z Yang L Chen Z Chen X Guo Y Wang X Dong X Wang T Zhang L Qiu Z Yang R Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: A cross-sectional survey in China Eur J Haematol 2007, 78(6):518-523. 10.1111/j.1600-0609.2007.00844.x 17419740
57. McMillan R Bussel JB George JN Lalla D Nichol JL Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura American Journal of Hematology 2007, 83(2):150-4. 17722072 10.1002/ajh.20992
58. Provan D Newland A Fifty years of idiopathic thrombocytopenic purpura (ITP): Management of refractory ITP in adults Br J Haematol 2002, 118(4):933-944. 10.1046/j.1365-2141.2002.03669.x 12199770
59. Cines DB James BB How I treat idiopathic thrombocytopenic purpura (ITP) Blood 2005, 106(7):2244-2250. 10.1182/blood-2004-12-4598 15941913
60. Moore M Hofer S McGee H Ring L Can the concepts of depression and quality of life be integrated using a time perspective? Health and quality of life outcomes 2005, 3:1. 10.1186/1477-7525-3-1 15634354 545054